Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia

Schizophrenia Research

Volumn 48, Issue 1, 2001, Pages 125-136

  Maurer, Iris ^a   Zierz, Stephan ^b   Möller, Hans Jürgen ^c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cytochrome c oxidase; Energy metabolism; Mitochondria; Oxidative phosphorylation; Respiratory chain; Schizophrenia

Indexed keywords

BRAIN ENZYME; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; AEROBIC METABOLISM; AGED; ARTICLE; BRAIN MITOCHONDRION; BRAIN REGION; CADAVER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; SCHIZOPHRENIA;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BRAIN; CASE-CONTROL STUDIES; CITRATE (SI)-SYNTHASE; CYTOCHROME-C OXIDASE DEFICIENCY; ELECTRON TRANSPORT COMPLEX I; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MULTIENZYME COMPLEXES; NADH, NADPH OXIDOREDUCTASES; OXIDATIVE PHOSPHORYLATION; SCHIZOPHRENIA; SPECTROPHOTOMETRY;

EID: 0035280535     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00075-X     Document Type: Article

References (40)

1. Sequence and organization of the human mitochondrial genome
2. Glucose metabolic rate in normals and schizophrenics during the continuous performance test assessed by positron emission tomography
3. Aging, energy and oxidative stress in neurodegenerative diseases
4. Age-dependent impairment of mitochondrial function in primate brain
5. Postmortem evidence of structural brain changes in schizophrenia: Differences in brain weight, temporal horn area and parahippocampal gyrus width as compared with affective disorder
6. The frontal lobes, basal ganglia and temporal lobes as sites for schizophrenia
7. Neuroleptic medications inhibit complex I of the electron transport chain
8. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics
9. Schizophrenia - A brain disease? A critical review of structural and functional cerebral abnormality in the disorder
10. Dysfunction in a prefrontal substrate of sustained attention in schizophrenia
11. The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia
12. Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: Effect of ageing
13. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders
14. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia
15. 31phosphorus magnetic resonance spectroscopic imaging study
16. Brain morphology in first episode schizophrenic like psychotic patients: A quantitative magnetic resonance imaging study
17. 31P magnetic resonance chemical shift imaging
18. Growing old: The most common mitochondrial disease of all?
19. Effect of neuroleptics on the mitochondrial electron transport chain
20. A reference base and system for analysis of muscle constituents
21. Protein measurement with the folin reagent
22. Aspects of oxidative metabolism in schizophrenia
23. Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics
24. Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease
25. A study of altered gene expression in frontal cortex from schizophrenic patients using differential screening
26. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naïve schizophrenics
27. 31P nuclear magnetic resonance spectroscopy: Neurodevelopment and schizophrenia
28. Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine
29. Neuroleptic-induced mitochondrial enzyme alterations in the rat brain
30. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia
31. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy
32. Temporal lobe pathology in schizophrenia: A quantitative magnetic resonance imaging study
33. An enzymological study on brain tissue of schizophrenic patients. Carbohydrate metabolism
34. Decline in skeletal muscle mitochondrial respiratory chain function: Possible factor in aging
35. Mitochondrial genetics: A paradigm for aging and degenerative diseases?
36. Mitochondrial DNA sequence variation in human evolution and disease
37. Mitochondrial involvement in schizophrenia and other functional psychoses
38. Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients
39. Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls
40. Decreased activities in mitochondrial inner membrane electron transport system in muscle from patients with Kearns-Sayre syndrome